Biography:
Dr. Zheng Wang is an expert in the field of precision medicine in oncology who performs practice in the precise diagnosis and personalized treatment of breast cancer. Dr. Wang is passionate about clinical and translational researches to make innovations in cancer therapies and to improve the overall survival and life quality of cancer patients.
Dr. Wang's significant contributions to the field of precision medicine in oncology include: 1. Clinical patterns and predictive models of cancer metastasis, 2. Novel targets and interventional strategies for cancer metastasis, 3. Immune microenvironment and metabolic reprogramming for modulating cancer metastasis.
Dr. Wang's work has resulted in 50 peer-reviewed scientific articles. Not only has Dr. Wang successfully completed and published the results of his research in some of the most discerning, high-impact journals in the field, but his discoveries have also gone on to influence his peers. That is, Dr. Wang's publications have been cited by researchers in at least 40 countries.
Dr. Wang serves on the editorial board of BMC Medicine, Cancer Drug Resistance, Discover Immunity, Frontiers in Oncology, Frontiers for Young Minds and Artificial Intelligence in Cancer. And Dr. Wang has conducted more than 100 reviews for 41 journals that include eBioMedicine, Frontiers in Immunology, Cell Death & Disease, Advanced Therapeutics, Frontiers in Bioengineering and Biotechnology, Aging, Molecular Carcinogenesis, and World Journal of Gastroenterology.
Title : Precision medicine and translational research of breast cancer